OR WAIT null SECS
Newton, MA, USA - February 11th, 2009-Clinical Data, Inc. (NASDAQ: CLDA) announces today that its Cogenics division, the global leader in outsourced genomics services, has launched CogenicsOnline, a personalized global e-commerce solution for the life sciences industry.
CogenicsOnline offers e-commerce services to its growing customer base in the healthcare and life science industries, as well as agricultural and academic partners. The online solution allows customers to obtain express sequencing and order other high-value services, including gene expression, genotyping and biomanufacturing support.
Customers will benefit from personalized, online access, enabling them to place their order in their 'preferred' way, supplement the order with additional pre and post treatment services, track the order processing status and grant levels of access to results in different electronic formats.
"We are very pleased to provide our customers with this unique and secure online system which is based on several years of hands-on experience with our French web service, Gexbyweb," said Paul Tomlin, Senior Vice President European Operations and Finance, Cogenics. "This new portal is a key step toward expanding our leadership position in the Express sequencing markets both in Europe and the U.S. It is also an integral part of the Company's strategy to offer the same highest quality genomic services in a cost-effective and more efficient manner, wherever these services are performed."
CogenicsOnline is available immediately in the United Kingdom and France, with initial online ordering capabilities for express sequencing. Cogenics plans to extend its online service geographically to include other European countries in the coming months, and will include the United States during the course of 2009. In addition, Cogenics intends to broaden the range of services that will be available to customers online in parallel with the geographic expansion.
Cogenics provides next generation sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction and biobanking for both research and regulated environments. Cogenics has two facilities in the USA - North Carolina and Texas, as well as in the United Kingdom, France and Germany.
Cogenics, a division of Clinical Data, Inc., has established itself as a leading provider of value-based genomics solutions for both the Healthcare and the Life Sciences industries. These solutions span the areas of current and next generation sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction and biobanking for both research and regulated environments. Cogenics customers include some of the world's most respected pharmaceutical and biotechnology companies, agencies of the US National Institutes of Health, leading government and academic researchers in the international life science community, and major agricultural companies and agencies. For more information, please visit www.cogenics.com.
About Clinical Data, Inc.
Clinical Data is a global biotechnology company unlocking the potential of molecular discovery, From Targeted Science to Better Healthcare(R). The Company's PGxHealth(R) division is utilizing its proprietary portfolio of biomarkers to develop and commercialize a broad range of targeted therapeutics as well as pharmacogenetic tests that help predict drug safety and efficacy, thereby reducing health care costs. Its Cogenics(R) division provides genomics services to both research and regulated environments. Through these divisions, Clinical Data is leveraging advances in molecular discovery to provide tangible benefits for patients, doctors, scientists and health plans worldwide. To learn more, please visit the Company's website at www.clda.com.